GRA57

GRA57 is a secreted dense granule protein of Toxoplasma gondii that acts within the parasitophorous vacuole to promote parasite survival in IFNγ-activated human cells (PMID:37459303). It functions as part of a heterotrimeric complex with GRA70 and GRA71, and CRISPR knockout of any component reduces parasite persistence in IFNγ-stimulated human foreskin fibroblasts, establishing the complex as a determinant of resistance to human cell-autonomous immunity (PMID:37459303). Loss of the complex also lowers host-mediated ubiquitination of the vacuole, but this is a secondary consequence of complex deletion rather than the direct basis of IFNγ resistance (PMID:37459303). GRA57 is expressed across life stages, having been identified as a bradyzoite-upregulated PV protein (PMID:32374791). Beyond its membership in the GRA57/GRA70/GRA71 complex and its role in IFNγ resistance, the molecular mechanism by which GRA57 protects the vacuole has not been characterized in the available corpus.

1. 2020 Low

   Before this work it was unknown whether GRA57 was parasite-secreted or where it localized; proximity labeling placed it in the parasitophorous vacuole and defined it as a bradyzoite-upregulated dense granule protein, establishing it as a secreted PV effector candidate.

   Evidence Proximity biotinylation with a MAG1-BirA* bait in bradyzoites followed by mass spectrometry

   PMID:32374791

   Open questions at the time

   • Single proximity-labeling/MS experiment with no mechanistic follow-up on GRA57
   • Does not establish any function or interaction partners
   • Tachyzoite-stage behavior not addressed
2. 2023 Medium

   The functional role of GRA57 was unresolved; a targeted CRISPR screen in IFNγ-activated human cells showed GRA57 assembles into a heterotrimeric complex with GRA70 and GRA71 that is required for parasite survival, defining a protein module underlying resistance to human cell-autonomous immunity.

   Evidence Targeted CRISPR screening in IFNγ-activated HFFs, complex identification, and individual gene knockouts with a parasite survival readout

   PMID:37459303

   Open questions at the time

   • Molecular activity of the complex and the direct effector mechanism protecting the vacuole are unknown
   • How the complex assembles and localizes within the PV is not defined
   • Single lab; identity of host targets counteracted by the complex not established
3. 2023 Medium

   Whether the complex acts by controlling vacuole ubiquitination was tested; knockout vacuoles showed reduced host-mediated ubiquitination, but this was interpreted as a downstream consequence rather than the direct cause of IFNγ resistance, separating the ubiquitination phenotype from the survival function.

   Evidence CRISPR knockout of complex components combined with ubiquitination assay of the parasitophorous vacuole in human cells

   PMID:37459303

   Open questions at the time

   • Causal link between the complex and vacuole ubiquitination not established; authors flag the interpretation as uncertain
   • The direct effector pathway responsible for IFNγ resistance remains unidentified

• The molecular mechanism by which the GRA57/GRA70/GRA71 complex protects the parasitophorous vacuole from IFNγ-driven human immunity, and the host targets it engages, remain unknown.
• No enzymatic or biochemical activity assigned to GRA57 or the complex
• No host binding partners or targeted immune effectors identified
• Relationship between vacuole ubiquitination and parasite survival unresolved